All Stories

  1. Prognostic performance of the ESC SCORE and its German recalibrated versions in primary and secondary prevention
  2. Identification of acute myocardial infarction in elderly patients using optimized highly sensitive troponin I thresholds
  3. Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
  4. Troponinwerte und der akute Myokardinfarkt
  5. Bone marrow and plasma FGF‐23 in heart failure patients: novel insights into the heart–bone axis
  6. Identification and regulation of the long non-coding RNA Heat2 in heart failure
  7. High-sensitivity cardiac troponin assays: finally ready for prime time?
  8. Anti-citrullinated protein antibodies are not associated with extent of disease or prognosis in patients with coronary artery disease
  9. Right bundle branch block in patients with suspected myocardial infarction
  10. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease
  11. Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis
  12. N-terminal pro–B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
  13. Improved risk stratification in prevention by use of a panel of selected circulating microRNAs
  14. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation
  15. Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex
  16. Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
  17. Influence of hypothermia and subsequent rewarming upon leukocyte-endothelial interactions and expression of Junctional-Adhesion-Molecules A and B
  18. Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model
  19. Strategies to overcome misdiagnosis of type 1 myocardial infarction using high sensitive cardiac troponin assays
  20. Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay
  21. Estimation of Values below the Limit of Detection of a Contemporary Sensitive Troponin I Assay Improves Diagnosis of Acute Myocardial Infarction
  22. Amyloid-Beta (1-40) and the Risk of Death From Cardiovascular Causes in Patients With Coronary Heart Disease
  23. Assessment of microRNAs in patients with unstable angina pectoris
  24. From heart to toe: Heart's contribution on peripheral microRNA levels
  25. Dialyse- und Ultrafiltrationsverfahren bei kardio-renalem Syndrom. Empfehlung der Arbeitsgemeinschaft „Herz – Niere“ der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. und der Deutschen Gesellschaft für Nephrologie e.V.
  26. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction
  27. Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study
  28. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis
  29. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay
  30. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population
  31. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease
  32. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application
  33. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health Study
  34. Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation
  35. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain
  36. Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome
  37. Diagnostic and Prognostic Performance of Myeloperoxidase Plasma Levels Compared With Sensitive Troponins in Patients Admitted With Acute Onset Chest Pain
  38. Cardiac troponin determination in the diagnosis of acute myocardial infarction
  39. Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction
  40. Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the Absence of Acute Coronary Syndrome
  41. Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study
  42. Reduktion der stationären Verweildauer bei Patienten mit akutem Koronarsyndrom durch Einrichtung einer Chest Pain Unit
  43. Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie
  44. A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease
  45. Making it More Sensitive
  46. Novel biomarkers in evaluation of acute coronary syndrome
  47. Tako-Tsubo syndrome: dying of a broken heart?
  48. Distribution and Categorization of Left Ventricular Measurements in the General Population
  49. Patientenzufriedenheit beim akuten Koronarsyndrom
  50. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction
  51. Improved outcome in acute coronary syndrome by establishing a chest pain unit
  52. Rolle von Biomarkern zur Risikostratifizierung in der Prävention kardiovaskulärer Erkrankungen
  53. Entwicklung der Chest-Pain-Units in Deutschland
  54. Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
  55. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
  56. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study
  57. Chest Pain Unit (CPU): erste Erfahrungen in Mainz
  58. Color Doppler Indices of Renal Allografts Depend on Vascular Stiffness of the Transplant Recipients